• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

262.82 +2.89 (+1.11%)
Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,145,196
Open 259.74
Bid (Size) 263.00 (100)
Ask (Size) 264.00 (100)
Prev. Close 259.93
Today's Range 257.87 - 264.06
52wk Range 190.75 - 269.39
Shares Outstanding N/A
Dividend Yield 2.63%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 of the Best ETFs to Buy and Hold if a Recession Is Coming ↗
Today 13:25 EDT
VHT, BND, and VOO could be your best bets in the next economic downturn. 
Via The Motley Fool
Topics ETFs Economy Regulatory Compliance
News headline image
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? ↗
October 01, 2026
AbbVie boasts stronger revenue growth and free cash flow, while Bristol Myers Squibb trades at half the valuation with nearly double the profit margin. 
Via The Motley Fool
Topics Economy

Performance

52-Week Range 2.4% below 52-week high
262.82
190.7552W Low 269.3952W High
1 Week 2.3% below 1-week high
259.001W Low 268.931W High

AbbVie (ABBV) traded between $190.75 and $269.39 over the past 52 weeks and last traded at $262.82, 2.4% below its 52-week high. Over the past week it ranged between $259.00 and $268.93.

Past 12 Months
-0.6%
+1.1%
+0.7%
+25.8%
+14.6%
+7.5%
1W -$1.52
1M +$2.83
3M +$1.75
6M +$53.98
YTD +$33.51
1Y +$18.44

ABBV was +7.5% over the past year, +25.8% over six months, +14.6% year to date, -0.6% in the last week.

12 Months vs Market
ABBV
+7.5%
DIA
+10.1%
SPY
+15.1%
QQQ
+24.3%
IWM
+16.1%

Over the past 12 months ABBV returned +7.5% versus DIA (Dow) +10.1%, SPY (S&P 500) +15.1%, QQQ (Nasdaq 100) +24.3% and IWM (Russell 2000) +16.1%.

Volume & Liquidity 1.24× 3-mo avg
Today 6,145,196 3-mo avg 5.0M
1W
3.9M
1M
4.1M
3M
5.0M
6M
6.0M
YTD
6.5M
1Y
6.3M

ABBV most recently traded 6,145,196 shares against a 3-month average daily volume of 5.0M.

More News

Read More
News headline image
AbbVie Stock: Buy, Sell, or Hold in October? ↗
September 30, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
3 Healthcare Dividend Stocks Offering More Than Just Income ↗
September 30, 2026
Via MarketBeat
News headline image
1 Profitable Stock to Keep an Eye On and 2 Facing Challenges
September 30, 2026
Via StockStory
Topics Supply Chain
News headline image
Kevin Warsh Just Signaled Higher-for-Longer Rates. Here's What That Means for Big Pharma Dividend Stocks. ↗
September 27, 2026
Via The Motley Fool
Topics Bonds Economy
News headline image
AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? ↗
September 25, 2026
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
News headline image
AbbVie vs. Pfizer: Which Healthcare Stock Makes Your Portfolio Healthier in 2026? ↗
September 25, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
AbbVie vs. Novo Nordisk: Which Drug Giant Stock Is a Better Buy in 2026? ↗
September 24, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
AbbVie vs. Eli Lilly: Which Star Pharma Stock Is a Better Buy in 2026? ↗
September 24, 2026
Via The Motley Fool
News headline image
Prediction: Here's What $10,000 Invested in AbbVie Stock With Dividends Reinvested Could Be Worth in a Decade ↗
September 24, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
AbbVie vs. Pfizer: Which Dividend Stock Is the Better Buy in September? ↗
September 22, 2026
Via The Motley Fool
News headline image
Reflecting On Therapeutics Stocks’ Q2 Earnings: AbbVie (NYSE:ABBV)
September 21, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
AbbVie's Migraine Franchise Scored a Big Win. Is This Dividend King a No-Brainer Buy Right Now? ↗
September 19, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? ↗
September 18, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Where Will Novo Nordisk Be in 5 Years as the GLP-1 Market Gets More Crowded? ↗
September 16, 2026
Via The Motley Fool
Topics Economy
News headline image
Is AbbVie the Best Dividend King to Buy in September? ↗
September 16, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
3 Dividend Stocks That Are No-Brainer Buys Right Now, Starting With This Healthcare Giant ↗
September 15, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
AbbVie Maps Post-HUMIRA Growth With Apogee Deal, Immunology Pipeline ↗
September 15, 2026
Via MarketBeat
Topics ETFs
News headline image
Billionaire Ken Griffin Just Loaded Up on This Dividend King, and Wall Street Still Sees Upside ↗
September 14, 2026
Via The Motley Fool
Topics Economy Intellectual Property
News headline image
AbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? ↗
September 14, 2026
Via The Motley Fool
News headline image
Why Did Billionaire Israel "Izzy" Englander More Than Double His Stake in AbbVie Stock and Start a Position in SpaceX Stock? ↗
September 12, 2026
Via The Motley Fool
Topics Artificial Intelligence
News headline image
AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026? ↗
September 10, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Here’s How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years ↗
September 09, 2026
Via Benzinga
News headline image
AbbVie Highlights SKYRIZI, RINVOQ Growth and Pipeline Catalysts at Wells Fargo Conference ↗
September 09, 2026
Via MarketBeat

Frequently Asked Questions

Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 262.82
When was AbbVie last traded?
The last trade of AbbVie was at 10/02/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap